The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below:
2nd Cancer Markers & Liquid Biopsies:
The role of cancer markers is significant towards the diagnosis, prognosis, and surveillance of a patient. Understanding markers and characterizing circulating elements with the latest technologies aid our progress toward the future of better personalized cancer care. Leaders in industry and academia will discuss platforms for isolating and studying CTCs. Technologies such as next generation sequencing and digital PCR are gaining momentum in these research areas. This meeting will also discuss biomarker sensitivity, stability, validation, and how we can use markers to follow up with patients and improve the quality of life.
There is a huge drive in Precision Medicine as it integrates research and clinical practice to build a knowledge base that can better guide individualized patient care. At a crucial time, where there are efforts to scale up population-based genome sequencing and integrate it with clinical data, this meeting will discuss the progress towards the implementation of precision medicine. This conference will discuss the future of healthcare, strategies and technologies for successful implementation, precision medicine beyond oncology, integrating and interpreting personal genomics, big data, bioinformatics, and overcoming challenges in the commercialization of precision medicine.
Digital PCR & qPCR:
There has been a push to find a faster and a more efficient way to optimize the quantification of nucleic acids. In the past, quantitative polymerase chain reaction (qPCR) has been the best way to measure the relative amplification of PCR in real time. In more recent years, digital PCR has become a newer method of PCR quantification that can result in absolute quantification, increased sensitivity in samples, more controllable precision, and multiple partitions of the same sample. This meeting will discuss the newest developments in digital PCR and qPCR in relation to how PCR can be used the molecular diagnostics field.
Clarifying contradictions in the characterization and isolation of extracellular vesicles, and identifying where the most promising opportunities for therapeutics and diagnostics lie, is proving to be one of the most attractive challenges of the decade for the global biomedical community.
We welcome you to take this opportunity to interact with this community and benefit from the expert knowledge of academic and industry leaders who are investigating these vital mediators of intercellular communication as potential targets for therapeutic innovation.
The NCRI Cancer Conference showcases the latest basic, translational and clinical cancer research. It brings researchers together to share ideas and develop collaborations.
Join us to share ideas, develop collaborations and be inspired by the latest UK and international research. Play your part in helping to showcase the ground-breaking research at the UK's largest cancer research meeting. The NCRI Cancer Conference is the platform for cancer research in the UK, featuring research of international calibre. Submit your abstract today and gain recognition from your peers.
Important dates for your diary:
Abstract Submission: 4 April – 5 June
Earlybird registration: 4 April – 30 June
Standard registration: 1 July – 30 September
Later breaking abstract submission: 1 August – 22 August